Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.2000 (2.48%) ($6.0000 - $6.3000) on Tue. Nov. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 54 | Latest Price | $6.2000(2.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(5%) EWG(4%) URA(4%) TBT(3%) EWI(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.03% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 0 () | Intraday Trend | 1.6% | | | |
|
Resistance Level | $6.26 | 5 Day Moving Average | $6.2(0%) | 10 Day Moving Average | $6.33(-2.05%) | 20 Day Moving Average | $6.26(-0.96%) | To recent high | -16.3% | To recent low | 10.7% | Market Cap | $513m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |